Search Within

Head and Neck Service

Formats
  1. Journal Article (412)
  2. Meeting Abstract (361)
  3. Book Section (21)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Solid Tumor Oncology Division (841)
  2. Department of Medicine (835)
  3. Surgery (363)
  4. Head and Neck Surgery (342)
  5. Radiation Oncology, Department of (314)
  6. Survivorship Research (312)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (346)
  3. Nancy Lee (270)
  4. Alan Ho (243)
  5. Nadeem Riaz (163)
  6. Richard Wong (143)

More People

Years
  1. 2025 (19)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (67)

More Years

Publications
  1. Journal of Clinical Oncology (208)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (29)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (222)
  2. Elsevier Inc. (176)
  3. Oxford University Press (55)
  4. Wiley Blackwell (54)
  5. American Association for Cancer Research (46)
  6. John Wiley & Sons, Inc. (29)

More Publishers

Results (841)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term update of a phase II study of concurrent chemoradiotherapy using radiation + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer (NPC): RTOG 0615
    Meeting Abstract

    Lee, N.; Harris, J.; Pfister, D. G.; Kim, J.; Garden, A. S.; Mechalakos, J. G.; Chan, A. T. C.; Hu, K. S.; Yom, S. S.; Glisson, B. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV positive oropharyngeal cancer (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E.; Pei, X.; Schoder, H.; Paudyal, R.; Katabi, N.; Ma, D. J.; Tsai, C. J.; McBride, S.; Morris, L. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Predictors of immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab
    Meeting Abstract

    Yu, Y.; Chen, L.; Riaz, N.; Tsai, C. J.; Kang, J. J.; Sherman, E.; Lee, N.; McBride, S.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Interim results from a phase 1/2 precision medicine study of PLX8394-a next generation BRAF inhibitor
    Meeting Abstract

    Janku, F.; Sherman, E. J.; Parikh, A. R.; Feun, L. G.; Tsai, F.; Allen, E.; Zhang, C.; Severson, P.; Inokuchi, K.; Walling, J.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer
    Meeting Abstract

    Shah, M. H.; Sherman, E. J.; Robinson, B.; Solomon, B. J.; Kang, H.; Lorch, J. H.; Worden, F. P.; Brose, M. S.; Leboulleux, S.; Godbert, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary activity of tipifarnib in tumors of the head and neck, salivary gland and urothelial tract with HRAS mutations
    Meeting Abstract

    Ho, A. L.; Hanna, G. J.; Scholz, C. R.; Gualberto, A.; Park, S. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II International Thyroid Oncology Group trial
    Meeting Abstract

    Haugen, B.; French, J.; Worden, F. P.; Konda, B.; Sherman, E. J.; Dadu, R.; Gianoukakis, A. G.; Wolfe, E. G.; Foster, N. R.; Bowles, D. W.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial
    Meeting Abstract

    Haugen, B.; French, J. D.; Worden, F.; Konda, B.; Sherman, E. J.; Dadu, R.; Gianoukakis, A. G.; McCue, S.; Foster, N.; Bowles, D. W.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save